OTC Markets OTCQB - Delayed Quote USD

Defence Therapeutics Inc. (DTCFF)

Compare
0.7500
0.0000
(0.00%)
At close: January 31 at 3:00:00 PM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
11,215.9500
12,821.8800
6,545.3600
7,320.1310
2,859.2540
Operating Income
-11,215.9500
-12,821.8800
-6,545.3600
-7,320.1310
-2,859.2540
Net Non Operating Interest Income Expense
-403.0270
-375.9680
-256.1240
--
--
Other Income Expense
16.2250
4.8030
-66.2990
23.8670
--
Pretax Income
-11,602.7520
-13,193.0450
-6,867.7830
-7,296.2640
-2,859.2540
Tax Provision
--
--
-105.0000
--
--
Net Income Common Stockholders
-11,602.7520
-13,193.0450
-6,762.7830
-7,343.9980
-2,859.2540
Diluted NI Available to Com Stockholders
-11,602.7520
-13,193.0450
-6,762.7830
-7,343.9980
-2,859.2540
Basic EPS
-0.26
-0.30
-0.17
-0.20
-0.11
Diluted EPS
-0.26
-0.30
-0.17
-0.20
-0.11
Basic Average Shares
45,045.4930
44,632.4210
39,660.2820
36,077.3230
26,596.1540
Diluted Average Shares
45,045.4930
44,632.4210
39,660.2820
36,077.3230
26,596.1540
Total Expenses
11,215.9500
12,821.8800
6,545.3600
7,320.1310
2,859.2540
Net Income from Continuing & Discontinued Operation
-11,602.7520
-13,193.0450
-6,762.7830
-7,343.9980
-2,859.2540
Normalized Income
-11,618.9770
-13,197.8480
-6,697.4976
-7,367.8650
-2,859.2540
Interest Income
6.8970
21.8860
6.8090
--
--
Interest Expense
409.9240
397.8540
262.9330
--
--
Net Interest Income
-403.0270
-375.9680
-256.1240
--
--
EBIT
-11,192.8280
-12,795.1910
-6,604.8500
-7,320.1310
-2,859.2540
EBITDA
-11,096.9810
-12,704.2670
-6,591.0270
-7,320.1310
-2,859.2540
Reconciled Depreciation
95.8470
90.9240
13.8230
--
--
Net Income from Continuing Operation Net Minority Interest
-11,602.7520
-13,193.0450
-6,762.7830
-7,343.9980
-2,859.2540
Total Unusual Items Excluding Goodwill
16.2250
4.8030
-66.2990
23.8670
--
Total Unusual Items
16.2250
4.8030
-66.2990
23.8670
--
Normalized EBITDA
-11,113.2060
-12,709.0700
-6,524.7280
-7,343.9980
-2,859.2540
Tax Rate for Calcs
--
--
0.0000
--
--
Tax Effect of Unusual Items
--
--
-1.0136
--
--
6/30/2021 - 5/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MMIRF MedMira Inc.
0.0847
0.00%
 
CLRPF Clarity Pharmaceuticals Ltd
2.3980
0.00%
 
MIR.V MedMira Inc.
0.1350
+3.85%
 
TELO Telomir Pharmaceuticals, Inc.
4.8600
+7.52%
 
BPMC Blueprint Medicines Corporation
112.53
-1.33%
 
MGX Metagenomi, Inc.
2.6900
-5.61%
 
ARGX argenx SE
655.13
-1.58%
 
NNVC NanoViricides, Inc.
1.2000
+12.15%
 
INKT MiNK Therapeutics, Inc.
9.16
+32.95%
 
CRMD CorMedix Inc.
10.27
-6.38%